Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,154,584
  • Shares Outstanding, K 1,382,930
  • Annual Sales, $ 9,048 M
  • Annual Income, $ 105,000 K
  • 36-Month Beta 0.59
  • Price/Sales 5.50
  • Price/Cash Flow 19.01
  • Price/Book 6.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.34
  • Number of Estimates 12
  • High Estimate 0.35
  • Low Estimate 0.33
  • Prior Year 0.31
  • Growth Rate Est. (year over year) +9.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.84 +3.21%
on 10/11/18
39.44 -6.21%
on 10/02/18
+0.55 (+1.51%)
since 09/12/18
3-Month
32.27 +14.63%
on 07/25/18
39.44 -6.21%
on 10/02/18
+3.65 (+10.95%)
since 07/12/18
52-Week
24.54 +50.73%
on 12/06/17
39.44 -6.21%
on 10/02/18
+7.56 (+25.69%)
since 10/12/17

Most Recent Stories

More News
Global Active Implantable Medical Devices Market 2018-2022: Key Vendors are Abbott, Biotronik, Boston Scientific, Cochlear, Medtronic & Sonova

The "Global Active Implantable Medical Devices Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

BSX : 36.99 (+2.75%)
Shares of BSX Up 30.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Boston Scientifc (NYSE:BSX) on April 16th, 2018 at $28.73. In approximately 6 months, Boston Scientifc has returned 30.56% as of today's recent price of $37.51.

BSX : 36.99 (+2.75%)
Here's Why You Should Invest in Boston Scientific Stock Now

Boston Scientific (BSX) is coming up with better-than-expected earnings and revenue performances on the back of growth across all business lines and geographies.

AMED : 109.28 (-3.71%)
BSX : 36.99 (+2.75%)
MASI : 117.13 (+2.19%)
ISRG : 532.02 (+4.68%)
Boston Scientifc Falls 2.25% on Heavy Volume: Watch For Potential Rebound

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $36.93 to a high of $37.88. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $37.65...

BSX : 36.99 (+2.75%)
After Yesterday's Decline of 2.25%, Boston Scientifc Offers Investors Better Value

Boston Scientifc (NYSE:BSX) traded in a range yesterday that spanned from a low of $36.93 to a high of $37.88. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $37.65...

BSX : 36.99 (+2.75%)
Next Support Level for Boston Scientifc (BSX) is $37.26

Boston Scientifc (NYSE:BSX) has opened bearishly below the pivot of $37.94 today and has reached the first level of support at $37.56. Analysts will be watching for a cross of the next downside pivot...

BSX : 36.99 (+2.75%)
Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BSX : 36.99 (+2.75%)
Boston Scientific Grows on Acquisitions, Product Launches

Boston Scientific's (BSX) strategy to extend its existing portfolio through inorganic growth profile has been advancing well. Further, this should help aid the company's top line in the long term.

AMED : 109.28 (-3.71%)
BSX : 36.99 (+2.75%)
MASI : 117.13 (+2.19%)
ISRG : 532.02 (+4.68%)
The Market for Neurotechnology (2018-2022): Projected to Reach $13.3 Billion by 2022 featuring Cochlear, Medtronic, Natus Medical, Advanced Bionics, Boston Scientific, Nihon-Kohden, and many more - ResearchAndMarkets.com

The "The Market for Neurotechnology: 2018-2022" report has been added to ResearchAndMarkets.com's offering.

BSX : 36.99 (+2.75%)
BABY : 32.01 (+0.44%)
Baxter (BAX) Collaborates With USC CBC to Digitize Healthcare

Baxter's (BAX) efforts to digitize healthcare solutions are likely to fortify its foothold in the highly competitive MedTech industry.

SYK : 171.04 (+1.38%)
BSX : 36.99 (+2.75%)
BAX : 71.25 (+1.54%)
MDT : 94.69 (+1.70%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade BSX with:

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

2nd Resistance Point 37.53
1st Resistance Point 37.26
Last Price 36.99
1st Support Level 36.64
2nd Support Level 36.28

See More

52-Week High 39.44
Last Price 36.99
Fibonacci 61.8% 33.75
Fibonacci 50% 31.99
Fibonacci 38.2% 30.23
52-Week Low 24.54

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar